309 related articles for article (PubMed ID: 17935903)
1. Direct comparison of biologically optimized spread-out bragg peaks for protons and carbon ions.
Wilkens JJ; Oelfke U
Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):262-6. PubMed ID: 17935903
[TBL] [Abstract][Full Text] [Related]
2. A mechanism-based approach to predict the relative biological effectiveness of protons and carbon ions in radiation therapy.
Frese MC; Yu VK; Stewart RD; Carlson DJ
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):442-50. PubMed ID: 22099045
[TBL] [Abstract][Full Text] [Related]
3. Modelling carcinogenesis after radiotherapy using Poisson statistics: implications for IMRT, protons and ions.
Jones B
J Radiol Prot; 2009 Jun; 29(2A):A143-57. PubMed ID: 19454805
[TBL] [Abstract][Full Text] [Related]
4. Comparison of optimized single and multifield irradiation plans of antiproton, proton and carbon ion beams.
Bassler N; Kantemiris I; Karaiskos P; Engelke J; Holzscheiter MH; Petersen JB
Radiother Oncol; 2010 Apr; 95(1):87-93. PubMed ID: 20304512
[TBL] [Abstract][Full Text] [Related]
5. Should positive phase III clinical trial data be required before proton beam therapy is more widely adopted? No.
Suit H; Kooy H; Trofimov A; Farr J; Munzenrider J; DeLaney T; Loeffler J; Clasie B; Safai S; Paganetti H
Radiother Oncol; 2008 Feb; 86(2):148-53. PubMed ID: 18237800
[TBL] [Abstract][Full Text] [Related]
6. Quantification of the relative biological effectiveness for ion beam radiotherapy: direct experimental comparison of proton and carbon ion beams and a novel approach for treatment planning.
Elsässer T; Weyrather WK; Friedrich T; Durante M; Iancu G; Krämer M; Kragl G; Brons S; Winter M; Weber KJ; Scholz M
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1177-83. PubMed ID: 20732758
[TBL] [Abstract][Full Text] [Related]
7. Biological characteristics of carbon-ion therapy.
Ando K; Kase Y
Int J Radiat Biol; 2009 Sep; 85(9):715-28. PubMed ID: 19728191
[TBL] [Abstract][Full Text] [Related]
8. Relative biological effectiveness variation along monoenergetic and modulated Bragg peaks of a 62-MeV therapeutic proton beam: a preclinical assessment.
Chaudhary P; Marshall TI; Perozziello FM; Manti L; Currell FJ; Hanton F; McMahon SJ; Kavanagh JN; Cirrone GA; Romano F; Prise KM; Schettino G
Int J Radiat Oncol Biol Phys; 2014 Sep; 90(1):27-35. PubMed ID: 24986743
[TBL] [Abstract][Full Text] [Related]
9. A model for the relative biological effectiveness of protons: the tissue specific parameter α/β of photons is a predictor for the sensitivity to LET changes.
Wedenberg M; Lind BK; Hårdemark B
Acta Oncol; 2013 Apr; 52(3):580-8. PubMed ID: 22909391
[TBL] [Abstract][Full Text] [Related]
10. The influence of RBE variations in a clinical proton treatment plan for a hypopharynx cancer.
Tilly N; Johansson J; Isacsson U; Medin J; Blomquist E; Grusell E; Glimelius B
Phys Med Biol; 2005 Jun; 50(12):2765-77. PubMed ID: 15930601
[TBL] [Abstract][Full Text] [Related]
11. Is the dose-averaged LET a reliable predictor for the relative biological effectiveness?
Grün R; Friedrich T; Traneus E; Scholz M
Med Phys; 2019 Feb; 46(2):1064-1074. PubMed ID: 30565705
[TBL] [Abstract][Full Text] [Related]
12. Biological effectiveness of (12)C and (20)Ne ions with very high LET.
Czub J; Banaś D; Błaszczyk A; Braziewicz J; Buraczewska I; Choinski J; Gorak U; Jaskoła M; Korman A; Lankoff A; Lisowska H; Lukaszek A; Szeflinski Z; Wojcik A
Int J Radiat Biol; 2008 Oct; 84(10):821-9. PubMed ID: 18979317
[TBL] [Abstract][Full Text] [Related]
13. Biophysical modelling of proton radiation effects based on amorphous track models.
Paganetti H; Goitein M
Int J Radiat Biol; 2001 Sep; 77(9):911-28. PubMed ID: 11576451
[TBL] [Abstract][Full Text] [Related]
14. Examination of GyE system for HIMAC carbon therapy.
Kanai T; Matsufuji N; Miyamoto T; Mizoe J; Kamada T; Tsuji H; Kato H; Baba M; Tsujii H
Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):650-6. PubMed ID: 16414376
[TBL] [Abstract][Full Text] [Related]
15. Radiotherapy systems using proton and carbon beams.
Jongen Y
Bull Mem Acad R Med Belg; 2008; 163(10-12):471-8; discussion 479-80. PubMed ID: 20120253
[TBL] [Abstract][Full Text] [Related]
16. High relative biologic effectiveness of carbon ion radiation on induction of rat mammary carcinoma and its lack of H-ras and Tp53 mutations.
Imaoka T; Nishimura M; Kakinuma S; Hatano Y; Ohmachi Y; Yoshinaga S; Kawano A; Maekawa A; Shimada Y
Int J Radiat Oncol Biol Phys; 2007 Sep; 69(1):194-203. PubMed ID: 17707273
[TBL] [Abstract][Full Text] [Related]
17. Antiproton radiotherapy.
Bassler N; Alsner J; Beyer G; DeMarco JJ; Doser M; Hajdukovic D; Hartley O; Iwamoto KS; Jäkel O; Knudsen HV; Kovacevic S; Møller SP; Overgaard J; Petersen JB; Solberg TD; Sørensen BS; Vranjes S; Wouters BG; Holzscheiter MH
Radiother Oncol; 2008 Jan; 86(1):14-9. PubMed ID: 18158194
[TBL] [Abstract][Full Text] [Related]
18. Assessment of potential advantages of relevant ions for particle therapy: a model based study.
Grün R; Friedrich T; Krämer M; Zink K; Durante M; Engenhart-Cabillic R; Scholz M
Med Phys; 2015 Feb; 42(2):1037-47. PubMed ID: 25652516
[TBL] [Abstract][Full Text] [Related]
19. What is the clinically relevant relative biologic effectiveness? A warning for fractionated treatments with high linear energy transfer radiation.
Daşu A; Toma-Daşu I
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(3):867-74. PubMed ID: 17889448
[TBL] [Abstract][Full Text] [Related]
20. Fractionation effects in particle radiotherapy: implications for hypo-fractionation regimes.
Carabe-Fernandez A; Dale RG; Hopewell JW; Jones B; Paganetti H
Phys Med Biol; 2010 Oct; 55(19):5685-700. PubMed ID: 20826903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
